Screenshot_2026-07-12-10-32-08-14_439a3fec0400f8974d35eed09a31f914.jpg
Can you give all questions ans in detail which is enough 10 mark short not
Reading File
Asking for Preferences
Ok
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
All 45 detailed answers for Chapter 5 are now complete. Here is a quick summary of what was covered:
All 45 Questions Answered - Quick Reference Index:
| Q No. | Topic |
|---|---|
| 44 | HIV/AIDS - Epidemiology, Prevention, Control (NACP, ART, 90-90-90) |
| 45 | H1N1 Pandemic Influenza - case definitions, Oseltamivir, categories |
| 46 | Food Poisoning Investigation - 5 steps: history, lab, animal, environment, attack rates |
| 47 | Japanese Encephalitis - Culex vector, pigs as reservoir, SA14-14-2 vaccine |
| 48 | Control of Diarrhoeal Disease - ORT, zinc, rotavirus vaccine, IMNCI |
| 49 | Chikungunya - Aedes vector, arthralgia hallmark, no vaccine, supportive care |
| 50 | Investigation of Cholera Epidemic - confirm, source, control, notification |
| 51 | Epidemiology of Filariasis - W. bancrofti, Culex vector, MDA, nocturnal periodicity |
| 52 | Prevention/Control of Rabies - PEP wound care, vaccine schedule, RIG, PreP |
| 53 | Hospital Acquired Infections - 5 types, ESKAPE organisms, bundles, hand hygiene |
| 54 | PEP for HIV / Modes of Transmission - TDF+3TC+DTG, 72-hour window |
| 55 | Dengue Clinical Management - WHO 3 groups, warning signs, fluid management |
| 56 | Prevention of ARI - PCV13, Hib, breastfeeding, IMNCI classification |
| 57 | Filarial Survey/MDA - HI, CI, BI indices; DEC+Albendazole; TAS |
| 58 | Typhoid Fever - Widal, blood culture, Vi-TT conjugate vaccine |
| 59 | Deformities in Leprosy - nerve damage, WHO grading, MCR footwear, POD |
| 60 | Yellow Fever Vaccine - 17D strain, Nobel Prize, lifelong immunity, contraindications |
| 61 | Homemade ORS - sugar-salt solution, rice water ORS, administration |
| 62 | Aedes aegypti Investigation - HI, CI, BI (Breteau Index), pupal index |
| 63 | MDT in Leprosy - PB (6 months), MB (12 months), ROM single dose, drug actions |
| 64 | BCG Vaccine - Calmette-Guerin, intradermal, scar, efficacy, adverse effects |
| 65 | DOTS/TB Prevention - 5 elements, NTEP, 2HRZE+4HR, TPT, Nikshay |
| 66 | Skin Test in Leprosy - Lepromin test, Fernandez + Mitsuda reactions, prognostic |
| 67 | Stable vs Unstable Malaria - transmission, immunity, epidemic potential comparison |
| 68 | Syndromic Approach in STDs - 5 syndromes, treatment regimens, advantages |
| 69 | SARS - 2002-03 outbreak, 8098 cases, isolation, PPE, no vaccine |
| 70 | Prevention/Control of Plague - rat/flea control order, Streptomycin, Doxycycline |
| 71 | Pulse Polio Immunization - 1995 launch, India polio-free 2014, bOPV switch 2016 |
| 72 | Measles Vaccine - Edmonston-Zagreb, MR vaccine, Vitamin A, herd immunity 92-95% |
| 73 | Social Factors in STDs - poverty, migration, sex work, stigma, 100% CUP |
| 74 | Hepatitis B Vaccine - recombinant, birth dose, HBIG, HBsAg+ mother management |
| 75 | Complications of Measles - pneumonia, SSPE, blindness, Vitamin A 200,000 IU |
| 76 | Malaria Treatment - Chloroquine+Primaquine (P. vivax), ACT (P. falciparum), severe |
| 77 | Control of Airborne Infections - isolation, UV, ventilation, vaccines, N95 |
| 78 | 17D Vaccine - Theiler Nobel Prize, chicken egg, lifetime validity certificate |
| 79 | Epidemiology TB + Yellow Fever - India 28% global burden; urban vs sylvatic YF |
| 80 | DPT Vaccine - components, schedule, do NOT freeze, adverse effects |
| 81 | Hepatitis A Prevention - fecal-oral, Havrix 2-dose, IgG prophylaxis, WASH |
| 82 | Antigenic Drift vs Shift - point mutations vs reassortment; epidemics vs pandemics |
| 83 | Prevention of Tetanus - TT schedule, 3 cleans, wound management table |
| 84 | Zika Virus - microcephaly, GBS, sexual transmission, congenital Zika syndrome |
| 85 | IPV vs OPV comparison - full table (mucosal immunity, VAPP, cold chain, cost) |
| 86 | Polio Endgame Strategy - GPEI 4 pillars, OPV withdrawal, nOPV2, containment |
| 87 | Natural History of TB - exposure → LTBI → 10% reactivation → 50% die untreated |
| 88 | Pneumonia in Child 2m-5y - IMNCI classification, fast breathing cutoffs, Amoxicillin |
All answers are written at the 10-mark detail level covering: definition, agent/etiology, epidemiology, clinical features, diagnosis, prevention and control - the standard format expected in community medicine exams.
This is a shared conversation. Sign in to Orris to start your own chat.